Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: a randomized study

Publication Type:

Journal Article

Source:

Liver Int, Volume 40, Issue 5, p.1042-1051 (2020)
Top